nodes	percent_of_prediction	percent_of_DWPC	metapath
Pancuronium—BCHE—kidney cancer	0.832	1	CbGaD
Pancuronium—CHRM3—ureter—kidney cancer	0.0219	0.369	CbGeAlD
Pancuronium—SLC22A2—nephron—kidney cancer	0.0151	0.255	CbGeAlD
Pancuronium—Pipecuronium—BCHE—kidney cancer	0.00335	0.706	CrCbGaD
Pancuronium—SLC22A2—nephron tubule—kidney cancer	0.00327	0.0551	CbGeAlD
Pancuronium—SLC22A2—renal system—kidney cancer	0.00297	0.0501	CbGeAlD
Pancuronium—SLC22A2—kidney—kidney cancer	0.00287	0.0484	CbGeAlD
Pancuronium—SLC22A2—cortex of kidney—kidney cancer	0.0028	0.0471	CbGeAlD
Pancuronium—Drug interaction—Erlotinib—kidney cancer	0.0022	0.0334	CcSEcCtD
Pancuronium—Paralysis—Vincristine—kidney cancer	0.00215	0.0327	CcSEcCtD
Pancuronium—SLC22A1—renal system—kidney cancer	0.0021	0.0354	CbGeAlD
Pancuronium—SLC22A1—kidney—kidney cancer	0.00203	0.0342	CbGeAlD
Pancuronium—Drug interaction—Sorafenib—kidney cancer	0.00198	0.0301	CcSEcCtD
Pancuronium—Respiratory failure—Sunitinib—kidney cancer	0.0018	0.0273	CcSEcCtD
Pancuronium—Redness—Paclitaxel—kidney cancer	0.00176	0.0267	CcSEcCtD
Pancuronium—CHRM3—renal system—kidney cancer	0.00174	0.0293	CbGeAlD
Pancuronium—CHRM3—kidney—kidney cancer	0.00168	0.0284	CbGeAlD
Pancuronium—Drug interaction—Vincristine—kidney cancer	0.00161	0.0245	CcSEcCtD
Pancuronium—BCHE—nephron tubule—kidney cancer	0.00156	0.0263	CbGeAlD
Pancuronium—Drug interaction—Gemcitabine—kidney cancer	0.00153	0.0232	CcSEcCtD
Pancuronium—Respiratory failure—Vincristine—kidney cancer	0.00152	0.0231	CcSEcCtD
Pancuronium—Respiratory failure—Gemcitabine—kidney cancer	0.00144	0.0219	CcSEcCtD
Pancuronium—Vecuronium—ABCB1—kidney cancer	0.00139	0.294	CrCbGaD
Pancuronium—Muscular weakness—Everolimus—kidney cancer	0.00135	0.0206	CcSEcCtD
Pancuronium—Bronchospasm—Everolimus—kidney cancer	0.0013	0.0198	CcSEcCtD
Pancuronium—Drug interaction—Paclitaxel—kidney cancer	0.00128	0.0194	CcSEcCtD
Pancuronium—BCHE—cardiac atrium—kidney cancer	0.00127	0.0214	CbGeAlD
Pancuronium—Flushing—Pazopanib—kidney cancer	0.00125	0.019	CcSEcCtD
Pancuronium—Erythema—Temsirolimus—kidney cancer	0.00124	0.0189	CcSEcCtD
Pancuronium—Respiratory failure—Paclitaxel—kidney cancer	0.00121	0.0184	CcSEcCtD
Pancuronium—Erythema—Pazopanib—kidney cancer	0.00117	0.0178	CcSEcCtD
Pancuronium—Muscular weakness—Sunitinib—kidney cancer	0.00113	0.0172	CcSEcCtD
Pancuronium—Anaphylactoid reaction—Gemcitabine—kidney cancer	0.00106	0.0162	CcSEcCtD
Pancuronium—Anaphylactic shock—Temsirolimus—kidney cancer	0.00101	0.0154	CcSEcCtD
Pancuronium—Flushing—Everolimus—kidney cancer	0.000985	0.015	CcSEcCtD
Pancuronium—Muscular weakness—Vincristine—kidney cancer	0.000956	0.0145	CcSEcCtD
Pancuronium—Redness—Doxorubicin—kidney cancer	0.00093	0.0141	CcSEcCtD
Pancuronium—Erythema—Everolimus—kidney cancer	0.000924	0.0141	CcSEcCtD
Pancuronium—Paralysis—Doxorubicin—kidney cancer	0.000903	0.0137	CcSEcCtD
Pancuronium—Erythema—Erlotinib—kidney cancer	0.000892	0.0136	CcSEcCtD
Pancuronium—Bronchospasm—Gemcitabine—kidney cancer	0.000875	0.0133	CcSEcCtD
Pancuronium—Flushing—Sorafenib—kidney cancer	0.000855	0.013	CcSEcCtD
Pancuronium—Flushing—Sunitinib—kidney cancer	0.000823	0.0125	CcSEcCtD
Pancuronium—Erythema—Sorafenib—kidney cancer	0.000802	0.0122	CcSEcCtD
Pancuronium—Flushing—Dactinomycin—kidney cancer	0.000779	0.0118	CcSEcCtD
Pancuronium—Erythema—Sunitinib—kidney cancer	0.000772	0.0117	CcSEcCtD
Pancuronium—Muscular weakness—Paclitaxel—kidney cancer	0.00076	0.0116	CcSEcCtD
Pancuronium—Hypersensitivity—Temsirolimus—kidney cancer	0.000747	0.0114	CcSEcCtD
Pancuronium—Tachycardia—Everolimus—kidney cancer	0.000736	0.0112	CcSEcCtD
Pancuronium—Erythema—Dactinomycin—kidney cancer	0.000731	0.0111	CcSEcCtD
Pancuronium—Hypotension—Everolimus—kidney cancer	0.000705	0.0107	CcSEcCtD
Pancuronium—Anaphylactic shock—Sorafenib—kidney cancer	0.000655	0.00996	CcSEcCtD
Pancuronium—Rash—Temsirolimus—kidney cancer	0.000639	0.00972	CcSEcCtD
Pancuronium—Dermatitis—Temsirolimus—kidney cancer	0.000639	0.00971	CcSEcCtD
Pancuronium—Muscular weakness—Capecitabine—kidney cancer	0.000623	0.00948	CcSEcCtD
Pancuronium—Erythema—Gemcitabine—kidney cancer	0.000619	0.00942	CcSEcCtD
Pancuronium—Salivary hypersecretion—Doxorubicin—kidney cancer	0.00061	0.00927	CcSEcCtD
Pancuronium—Rash—Pazopanib—kidney cancer	0.000602	0.00916	CcSEcCtD
Pancuronium—Dermatitis—Pazopanib—kidney cancer	0.000602	0.00915	CcSEcCtD
Pancuronium—Bronchospasm—Capecitabine—kidney cancer	0.000601	0.00914	CcSEcCtD
Pancuronium—Hypersensitivity—Vinblastine—kidney cancer	0.000558	0.00848	CcSEcCtD
Pancuronium—Hypersensitivity—Everolimus—kidney cancer	0.000556	0.00845	CcSEcCtD
Pancuronium—Flushing—Paclitaxel—kidney cancer	0.000553	0.00841	CcSEcCtD
Pancuronium—Anaphylactic shock—Vincristine—kidney cancer	0.000533	0.0081	CcSEcCtD
Pancuronium—Erythema—Paclitaxel—kidney cancer	0.000519	0.00789	CcSEcCtD
Pancuronium—Anaphylactic shock—Gemcitabine—kidney cancer	0.000506	0.00769	CcSEcCtD
Pancuronium—Hypotension—Vincristine—kidney cancer	0.000498	0.00757	CcSEcCtD
Pancuronium—Hypersensitivity—Sorafenib—kidney cancer	0.000482	0.00734	CcSEcCtD
Pancuronium—Rash—Everolimus—kidney cancer	0.000476	0.00723	CcSEcCtD
Pancuronium—Dermatitis—Everolimus—kidney cancer	0.000475	0.00723	CcSEcCtD
Pancuronium—Hypotension—Gemcitabine—kidney cancer	0.000472	0.00718	CcSEcCtD
Pancuronium—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.000471	0.00716	CcSEcCtD
Pancuronium—Hypersensitivity—Sunitinib—kidney cancer	0.000464	0.00706	CcSEcCtD
Pancuronium—Rash—Erlotinib—kidney cancer	0.000459	0.00698	CcSEcCtD
Pancuronium—Dermatitis—Erlotinib—kidney cancer	0.000458	0.00697	CcSEcCtD
Pancuronium—Flushing—Capecitabine—kidney cancer	0.000454	0.0069	CcSEcCtD
Pancuronium—Hypersensitivity—Dactinomycin—kidney cancer	0.000439	0.00668	CcSEcCtD
Pancuronium—Erythema—Capecitabine—kidney cancer	0.000426	0.00647	CcSEcCtD
Pancuronium—Anaphylactic shock—Paclitaxel—kidney cancer	0.000423	0.00644	CcSEcCtD
Pancuronium—Tachycardia—Paclitaxel—kidney cancer	0.000413	0.00628	CcSEcCtD
Pancuronium—Rash—Sorafenib—kidney cancer	0.000413	0.00628	CcSEcCtD
Pancuronium—Dermatitis—Sorafenib—kidney cancer	0.000412	0.00627	CcSEcCtD
Pancuronium—Muscular weakness—Doxorubicin—kidney cancer	0.000402	0.00611	CcSEcCtD
Pancuronium—Rash—Sunitinib—kidney cancer	0.000397	0.00604	CcSEcCtD
Pancuronium—Dermatitis—Sunitinib—kidney cancer	0.000397	0.00604	CcSEcCtD
Pancuronium—Hypotension—Paclitaxel—kidney cancer	0.000396	0.00601	CcSEcCtD
Pancuronium—Hypersensitivity—Vincristine—kidney cancer	0.000393	0.00597	CcSEcCtD
Pancuronium—Rash—Dactinomycin—kidney cancer	0.000376	0.00572	CcSEcCtD
Pancuronium—Tachycardia—Capecitabine—kidney cancer	0.000339	0.00516	CcSEcCtD
Pancuronium—Rash—Vincristine—kidney cancer	0.000336	0.00511	CcSEcCtD
Pancuronium—Dermatitis—Vincristine—kidney cancer	0.000336	0.0051	CcSEcCtD
Pancuronium—Hypotension—Capecitabine—kidney cancer	0.000325	0.00494	CcSEcCtD
Pancuronium—Rash—Gemcitabine—kidney cancer	0.000319	0.00485	CcSEcCtD
Pancuronium—Dermatitis—Gemcitabine—kidney cancer	0.000318	0.00484	CcSEcCtD
Pancuronium—Hypersensitivity—Paclitaxel—kidney cancer	0.000312	0.00474	CcSEcCtD
Pancuronium—Flushing—Doxorubicin—kidney cancer	0.000293	0.00445	CcSEcCtD
Pancuronium—Erythema—Doxorubicin—kidney cancer	0.000274	0.00417	CcSEcCtD
Pancuronium—Rash—Paclitaxel—kidney cancer	0.000267	0.00406	CcSEcCtD
Pancuronium—Dermatitis—Paclitaxel—kidney cancer	0.000267	0.00405	CcSEcCtD
Pancuronium—Hypersensitivity—Capecitabine—kidney cancer	0.000256	0.00389	CcSEcCtD
Pancuronium—Anaphylactic shock—Doxorubicin—kidney cancer	0.000224	0.0034	CcSEcCtD
Pancuronium—Rash—Capecitabine—kidney cancer	0.000219	0.00333	CcSEcCtD
Pancuronium—Dermatitis—Capecitabine—kidney cancer	0.000219	0.00333	CcSEcCtD
Pancuronium—Tachycardia—Doxorubicin—kidney cancer	0.000219	0.00332	CcSEcCtD
Pancuronium—Hypotension—Doxorubicin—kidney cancer	0.000209	0.00318	CcSEcCtD
Pancuronium—Hypersensitivity—Doxorubicin—kidney cancer	0.000165	0.00251	CcSEcCtD
Pancuronium—Rash—Doxorubicin—kidney cancer	0.000141	0.00215	CcSEcCtD
Pancuronium—Dermatitis—Doxorubicin—kidney cancer	0.000141	0.00214	CcSEcCtD
Pancuronium—BCHE—Neuronal System—RAF1—kidney cancer	3.37e-05	0.000882	CbGpPWpGaD
Pancuronium—SLC22A1—Neuronal System—BRAF—kidney cancer	3.36e-05	0.00088	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—PGK1—kidney cancer	3.33e-05	0.000872	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—SLC5A3—kidney cancer	3.33e-05	0.000872	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—ST3GAL2—kidney cancer	3.31e-05	0.000868	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—GPC3—kidney cancer	3.3e-05	0.000866	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—AMER1—kidney cancer	3.3e-05	0.000864	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—AMER1—kidney cancer	3.26e-05	0.000856	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—LDHB—kidney cancer	3.26e-05	0.000855	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—ALDH1A1—kidney cancer	3.23e-05	0.000848	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—CA2—kidney cancer	3.21e-05	0.000843	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—AKAP13—kidney cancer	3.21e-05	0.00084	CbGpPWpGaD
Pancuronium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—kidney cancer	3.19e-05	0.000836	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—AKAP13—kidney cancer	3.17e-05	0.000832	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—CA9—kidney cancer	3.17e-05	0.000831	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—ALAD—kidney cancer	3.13e-05	0.000821	CbGpPWpGaD
Pancuronium—CHRM2—SIDS Susceptibility Pathways—VEGFA—kidney cancer	3.11e-05	0.000815	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—PGK1—kidney cancer	3.1e-05	0.000813	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—SLC5A3—kidney cancer	3.1e-05	0.000813	CbGpPWpGaD
Pancuronium—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3.1e-05	0.000812	CbGpPWpGaD
Pancuronium—CHRM3—Regulation of Actin Cytoskeleton—MAPK3—kidney cancer	3.08e-05	0.000808	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—ST3GAL2—kidney cancer	3.06e-05	0.000802	CbGpPWpGaD
Pancuronium—CHRM2—Regulation of Actin Cytoskeleton—MAPK3—kidney cancer	3.05e-05	0.0008	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—LDHB—kidney cancer	3.04e-05	0.000797	CbGpPWpGaD
Pancuronium—BCHE—Transmission across Chemical Synapses—MAPK1—kidney cancer	3.01e-05	0.00079	CbGpPWpGaD
Pancuronium—SLC22A2—Neuronal System—RAF1—kidney cancer	3.01e-05	0.000788	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—ITPR2—kidney cancer	3e-05	0.000787	CbGpPWpGaD
Pancuronium—BCHE—Metabolism of proteins—IGF2—kidney cancer	2.99e-05	0.000783	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—ALDH1A1—kidney cancer	2.99e-05	0.000783	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—ITPR2—kidney cancer	2.97e-05	0.000779	CbGpPWpGaD
Pancuronium—CHRM3—Regulation of Actin Cytoskeleton—MAPK1—kidney cancer	2.93e-05	0.000769	CbGpPWpGaD
Pancuronium—CHRM2—Regulation of Actin Cytoskeleton—MAPK1—kidney cancer	2.9e-05	0.000761	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—PGK1—kidney cancer	2.86e-05	0.000751	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—SLC5A3—kidney cancer	2.86e-05	0.000751	CbGpPWpGaD
Pancuronium—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	2.86e-05	0.000751	CbGpPWpGaD
Pancuronium—SLC22A2—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.86e-05	0.000749	CbGpPWpGaD
Pancuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	2.84e-05	0.000743	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—CA9—kidney cancer	2.83e-05	0.000742	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—LDHB—kidney cancer	2.81e-05	0.000737	CbGpPWpGaD
Pancuronium—SLC22A1—Neuronal System—RAF1—kidney cancer	2.8e-05	0.000735	CbGpPWpGaD
Pancuronium—CHRM3—Regulation of Actin Cytoskeleton—KRAS—kidney cancer	2.77e-05	0.000726	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—GPC3—kidney cancer	2.76e-05	0.000724	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CER1—kidney cancer	2.76e-05	0.000724	CbGpPWpGaD
Pancuronium—CHRM2—Regulation of Actin Cytoskeleton—KRAS—kidney cancer	2.74e-05	0.000719	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—GPC3—kidney cancer	2.74e-05	0.000717	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CER1—kidney cancer	2.74e-05	0.000717	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—ITPR2—kidney cancer	2.73e-05	0.000715	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—ITPR2—kidney cancer	2.7e-05	0.000708	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—CRABP1—kidney cancer	2.69e-05	0.000706	CbGpPWpGaD
Pancuronium—SLC22A2—Transmission across Chemical Synapses—MAPK1—kidney cancer	2.69e-05	0.000706	CbGpPWpGaD
Pancuronium—SLC22A1—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.66e-05	0.000698	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—CA9—kidney cancer	2.64e-05	0.000691	CbGpPWpGaD
Pancuronium—CHRM3—Regulation of Actin Cytoskeleton—PIK3CA—kidney cancer	2.54e-05	0.000667	CbGpPWpGaD
Pancuronium—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—kidney cancer	2.52e-05	0.000661	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—ANXA1—kidney cancer	2.52e-05	0.000659	CbGpPWpGaD
Pancuronium—SLC22A1—Transmission across Chemical Synapses—MAPK1—kidney cancer	2.51e-05	0.000658	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—ITPR2—kidney cancer	2.5e-05	0.000657	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—ANXA1—kidney cancer	2.49e-05	0.000653	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—CA9—kidney cancer	2.44e-05	0.000639	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—CRABP1—kidney cancer	2.41e-05	0.000631	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—SFRP2—kidney cancer	2.35e-05	0.000616	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—SFRP2—kidney cancer	2.33e-05	0.00061	CbGpPWpGaD
Pancuronium—BCHE—Neuronal System—MAPK1—kidney cancer	2.31e-05	0.000605	CbGpPWpGaD
Pancuronium—BCHE—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.31e-05	0.000605	CbGpPWpGaD
Pancuronium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—kidney cancer	2.3e-05	0.000603	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—ANXA1—kidney cancer	2.28e-05	0.000599	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—GSTT1—kidney cancer	2.28e-05	0.000599	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—ACHE—kidney cancer	2.28e-05	0.000599	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—ANXA1—kidney cancer	2.26e-05	0.000593	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—CRABP1—kidney cancer	2.24e-05	0.000588	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—ITPR2—kidney cancer	2.24e-05	0.000586	CbGpPWpGaD
Pancuronium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—kidney cancer	2.19e-05	0.000573	CbGpPWpGaD
Pancuronium—CHRM3—GPCR ligand binding—POMC—kidney cancer	2.18e-05	0.000572	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—SCARB1—kidney cancer	2.16e-05	0.000567	CbGpPWpGaD
Pancuronium—CHRM2—GPCR ligand binding—POMC—kidney cancer	2.16e-05	0.000566	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—PTGS1—kidney cancer	2.14e-05	0.000561	CbGpPWpGaD
Pancuronium—CHRM3—G alpha (q) signalling events—PIK3CA—kidney cancer	2.12e-05	0.000556	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—PSMD7—kidney cancer	2.1e-05	0.00055	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—ITPR2—kidney cancer	2.08e-05	0.000547	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—CRABP1—kidney cancer	2.07e-05	0.000543	CbGpPWpGaD
Pancuronium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—kidney cancer	2.07e-05	0.000541	CbGpPWpGaD
Pancuronium—SLC22A2—Neuronal System—MAPK1—kidney cancer	2.06e-05	0.000541	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—ACHE—kidney cancer	2.04e-05	0.000535	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—GSTT1—kidney cancer	2.04e-05	0.000535	CbGpPWpGaD
Pancuronium—BCHE—Metabolism of proteins—POMC—kidney cancer	1.99e-05	0.000523	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—SLC5A5—kidney cancer	1.96e-05	0.000515	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—SCARB1—kidney cancer	1.93e-05	0.000506	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—ITPR2—kidney cancer	1.93e-05	0.000505	CbGpPWpGaD
Pancuronium—SLC22A1—Neuronal System—MAPK1—kidney cancer	1.92e-05	0.000504	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—PTGS1—kidney cancer	1.91e-05	0.000501	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—ACHE—kidney cancer	1.9e-05	0.000498	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—GSTT1—kidney cancer	1.9e-05	0.000498	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—SLC2A1—kidney cancer	1.9e-05	0.000498	CbGpPWpGaD
Pancuronium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—kidney cancer	1.9e-05	0.000497	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—AKAP13—kidney cancer	1.89e-05	0.000496	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CASP2—kidney cancer	1.89e-05	0.000496	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CASP2—kidney cancer	1.88e-05	0.000492	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—AKAP13—kidney cancer	1.88e-05	0.000492	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—PSMD7—kidney cancer	1.87e-05	0.000491	CbGpPWpGaD
Pancuronium—BCHE—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.84e-05	0.000483	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—SCARB1—kidney cancer	1.8e-05	0.000472	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—PTGS1—kidney cancer	1.78e-05	0.000467	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—BCHE—kidney cancer	1.78e-05	0.000466	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—GSTT1—kidney cancer	1.76e-05	0.00046	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—ACHE—kidney cancer	1.76e-05	0.00046	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—SLC5A5—kidney cancer	1.75e-05	0.00046	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—PSMD7—kidney cancer	1.75e-05	0.000458	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—GRB7—kidney cancer	1.73e-05	0.000454	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—GRB7—kidney cancer	1.71e-05	0.00045	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—SLC2A1—kidney cancer	1.69e-05	0.000444	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—SCARB1—kidney cancer	1.66e-05	0.000436	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—BCHE—kidney cancer	1.66e-05	0.000434	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—PTGS1—kidney cancer	1.65e-05	0.000431	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—SLC5A5—kidney cancer	1.64e-05	0.000429	CbGpPWpGaD
Pancuronium—SLC22A2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.62e-05	0.000424	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—PSMD7—kidney cancer	1.61e-05	0.000423	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—ITPR2—kidney cancer	1.61e-05	0.000422	CbGpPWpGaD
Pancuronium—BCHE—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.61e-05	0.000421	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—ITPR2—kidney cancer	1.59e-05	0.000418	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—GSTP1—kidney cancer	1.58e-05	0.000415	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—SLC2A1—kidney cancer	1.58e-05	0.000414	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—BCHE—kidney cancer	1.53e-05	0.000401	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—SLC5A5—kidney cancer	1.51e-05	0.000396	CbGpPWpGaD
Pancuronium—SLC22A1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.51e-05	0.000395	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—ABCB1—kidney cancer	1.5e-05	0.000393	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CTNNA1—kidney cancer	1.46e-05	0.000383	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—SLC2A1—kidney cancer	1.46e-05	0.000383	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—GSTM1—kidney cancer	1.45e-05	0.000381	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—EIF4EBP1—kidney cancer	1.45e-05	0.00038	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—HSPB1—kidney cancer	1.45e-05	0.00038	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CTNNA1—kidney cancer	1.45e-05	0.000379	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—EIF4EBP1—kidney cancer	1.44e-05	0.000377	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—HSPB1—kidney cancer	1.44e-05	0.000377	CbGpPWpGaD
Pancuronium—BCHE—Metabolism of proteins—CTNNB1—kidney cancer	1.42e-05	0.000373	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—GSTP1—kidney cancer	1.41e-05	0.000371	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—CYP1A1—kidney cancer	1.38e-05	0.000362	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—TSC1—kidney cancer	1.35e-05	0.000354	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PSMD7—kidney cancer	1.35e-05	0.000354	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—ANXA1—kidney cancer	1.35e-05	0.000354	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—ABCB1—kidney cancer	1.34e-05	0.000351	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PSMD7—kidney cancer	1.34e-05	0.00035	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—TSC1—kidney cancer	1.34e-05	0.00035	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—ANXA1—kidney cancer	1.34e-05	0.00035	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—GSTP1—kidney cancer	1.32e-05	0.000345	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—FLT1—kidney cancer	1.31e-05	0.000343	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—GSTM1—kidney cancer	1.3e-05	0.000341	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—FLT1—kidney cancer	1.29e-05	0.000339	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—ABCB1—kidney cancer	1.25e-05	0.000327	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—POMC—kidney cancer	1.23e-05	0.000323	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—CYP1A1—kidney cancer	1.23e-05	0.000323	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—POMC—kidney cancer	1.22e-05	0.00032	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—GSTP1—kidney cancer	1.22e-05	0.000319	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PAK1—kidney cancer	1.21e-05	0.000318	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—JUNB—kidney cancer	1.21e-05	0.000318	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—GSTM1—kidney cancer	1.21e-05	0.000317	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—JUNB—kidney cancer	1.2e-05	0.000314	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PAK1—kidney cancer	1.2e-05	0.000314	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—ABCB1—kidney cancer	1.15e-05	0.000302	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—CYP1A1—kidney cancer	1.15e-05	0.000301	CbGpPWpGaD
Pancuronium—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.13e-05	0.000297	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—POMC—kidney cancer	1.12e-05	0.000293	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—GSTM1—kidney cancer	1.12e-05	0.000293	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—POMC—kidney cancer	1.11e-05	0.000291	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—CYP1A1—kidney cancer	1.06e-05	0.000278	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—POMC—kidney cancer	1.03e-05	0.00027	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—IGF2—kidney cancer	9.9e-06	0.00026	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CDKN2B—kidney cancer	9.86e-06	0.000259	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—IGF2—kidney cancer	9.81e-06	0.000257	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CDKN2B—kidney cancer	9.76e-06	0.000256	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—IGF1R—kidney cancer	9.57e-06	0.000251	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—IGF1R—kidney cancer	9.48e-06	0.000249	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—RAF1—kidney cancer	9.23e-06	0.000242	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—POMC—kidney cancer	9.18e-06	0.000241	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—RAF1—kidney cancer	9.14e-06	0.00024	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—IL2—kidney cancer	9.11e-06	0.000239	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—IL2—kidney cancer	9.02e-06	0.000237	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—POMC—kidney cancer	8.56e-06	0.000224	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—IL2—kidney cancer	8.27e-06	0.000217	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—PTGS2—kidney cancer	8.2e-06	0.000215	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—IL2—kidney cancer	8.19e-06	0.000215	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—POMC—kidney cancer	7.9e-06	0.000207	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—HIF1A—kidney cancer	7.88e-06	0.000207	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—TSC2—kidney cancer	7.86e-06	0.000206	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—HIF1A—kidney cancer	7.81e-06	0.000205	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—TSC2—kidney cancer	7.79e-06	0.000204	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—KDR—kidney cancer	7.54e-06	0.000198	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—KDR—kidney cancer	7.46e-06	0.000196	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—PTGS2—kidney cancer	7.32e-06	0.000192	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—PTEN—kidney cancer	7.15e-06	0.000187	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—APC—kidney cancer	6.94e-06	0.000182	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—KIT—kidney cancer	6.94e-06	0.000182	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—APC—kidney cancer	6.88e-06	0.00018	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—KIT—kidney cancer	6.88e-06	0.00018	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—PTGS2—kidney cancer	6.83e-06	0.000179	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—MAPK3—kidney cancer	6.65e-06	0.000174	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—POMC—kidney cancer	6.61e-06	0.000173	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—MAPK3—kidney cancer	6.59e-06	0.000173	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—POMC—kidney cancer	6.55e-06	0.000172	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—BRAF—kidney cancer	6.53e-06	0.000171	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—BRAF—kidney cancer	6.46e-06	0.000169	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—PTEN—kidney cancer	6.39e-06	0.000167	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—MAPK1—kidney cancer	6.33e-06	0.000166	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—PTGS2—kidney cancer	6.31e-06	0.000165	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—MAPK1—kidney cancer	6.27e-06	0.000164	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—PIK3CA—kidney cancer	6.05e-06	0.000159	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—PIK3CA—kidney cancer	5.99e-06	0.000157	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—KRAS—kidney cancer	5.98e-06	0.000157	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—PTEN—kidney cancer	5.95e-06	0.000156	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—KRAS—kidney cancer	5.92e-06	0.000155	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—PTEN—kidney cancer	5.5e-06	0.000144	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—PIK3CA—kidney cancer	5.49e-06	0.000144	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—RAF1—kidney cancer	5.45e-06	0.000143	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—PIK3CA—kidney cancer	5.44e-06	0.000143	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—RELA—kidney cancer	5.43e-06	0.000142	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—RAF1—kidney cancer	5.4e-06	0.000142	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—ERBB2—kidney cancer	5.39e-06	0.000141	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—RELA—kidney cancer	5.37e-06	0.000141	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—ERBB2—kidney cancer	5.34e-06	0.00014	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—MTOR—kidney cancer	5.32e-06	0.00014	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—MTOR—kidney cancer	5.27e-06	0.000138	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—PIK3CA—kidney cancer	5.04e-06	0.000132	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CDKN1B—kidney cancer	4.99e-06	0.000131	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CDKN1B—kidney cancer	4.94e-06	0.00013	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—IL2—kidney cancer	4.89e-06	0.000128	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—IL2—kidney cancer	4.84e-06	0.000127	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CCND1—kidney cancer	4.76e-06	0.000125	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—JUN—kidney cancer	4.75e-06	0.000125	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CCND1—kidney cancer	4.72e-06	0.000124	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CTNNB1—kidney cancer	4.72e-06	0.000124	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—JUN—kidney cancer	4.71e-06	0.000123	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CTNNB1—kidney cancer	4.67e-06	0.000122	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PTEN—kidney cancer	4.6e-06	0.000121	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PTEN—kidney cancer	4.55e-06	0.000119	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—PIK3CA—kidney cancer	4.51e-06	0.000118	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—PIK3CA—kidney cancer	4.2e-06	0.00011	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—VEGFA—kidney cancer	4.15e-06	0.000109	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—VEGFA—kidney cancer	4.11e-06	0.000108	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—MAPK3—kidney cancer	3.93e-06	0.000103	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—MAPK3—kidney cancer	3.89e-06	0.000102	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—PIK3CA—kidney cancer	3.88e-06	0.000102	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—MYC—kidney cancer	3.82e-06	0.0001	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—MYC—kidney cancer	3.78e-06	9.92e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—MAPK1—kidney cancer	3.74e-06	9.8e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—MAPK1—kidney cancer	3.7e-06	9.71e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—KRAS—kidney cancer	3.53e-06	9.26e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—KRAS—kidney cancer	3.5e-06	9.17e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PIK3CA—kidney cancer	3.24e-06	8.5e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PIK3CA—kidney cancer	3.21e-06	8.42e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—TP53—kidney cancer	3.14e-06	8.23e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—TP53—kidney cancer	3.11e-06	8.15e-05	CbGpPWpGaD
